Clinical Trials & COVID-19

ReNeu Study

What is the purpose of the ReNeu study?

The purpose of this study is to determine the effectiveness of the study drug at improving a plexiform neurofibroma (PN) that is causing significant issues in people with Neurofibromatosis type 1 (NF1).

Who can join the ReNeu study?

Young girl with glasses smiling for camera

Participants in the ReNeu study must meet the following requirements*:

*Other requirements will apply.

What will happen during the study?

Participation in the ReNeu study will last up to 26 months (a little over 2 years).

During this time, participants can expect the following:

Participants may also have the option to continue taking the study drug for additional cycles as part of a Long-term Follow-up Phase.